Loading company…
Micell Technologies develops biopolymers, drugs and biomedical solutions for cardiovascular disease.
Micell Technologies develops biopolymers, drugs and other biomedical solutions to treat cardiovascular diseases. The company was founded in 1995 and is based in North Carolina, US. It is at the Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in